Renaissance Technologies's RNA Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 45,100 shares of Avidity Biosciences, Inc. (RNA) worth $3.25 M, representing 0.01% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in RNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2024, adding 377,400 shares. Largest reduction occurred in Q2 2023, reducing 309,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Avidity Biosciences (RNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avidity Biosciences (RNA) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2021 | +11,600 | New Buy | 11,600 | $23.79 |
| Q1 2022 | +26,800 | Add 231.03% | 38,400 | $18.46 |
| Q2 2022 | +69,900 | Add 182.03% | 108,300 | $14.53 |
| Q3 2022 | +15,700 | Add 14.50% | 124,000 | $16.33 |
| Q4 2022 | +42,600 | Add 34.35% | 166,600 | $0.02 |
| Q1 2023 | +208,500 | Add 125.15% | 375,100 | $0.02 |
| Q2 2023 | -309,200 | Reduce 82.43% | 65,900 | $0.01 |
| Q3 2023 | +44,900 | Add 68.13% | 110,800 | $6.38 |
| Q4 2023 | +115,900 | Add 104.60% | 226,700 | $9.05 |
| Q1 2024 | -226,700 | Sold Out | 0 | $0.00 |
| Q2 2024 | +377,400 | New Buy | 377,400 | $40.85 |
| Q3 2024 | -235,500 | Reduce 62.40% | 141,900 | $45.93 |
| Q4 2024 | +69,300 | Add 48.84% | 211,200 | $29.08 |
| Q1 2025 | -211,200 | Sold Out | 0 | $0.00 |
| Q4 2025 | +45,100 | New Buy | 45,100 | $72.13 |
Renaissance Technologies's Avidity Biosciences Investment FAQs
Renaissance Technologies first purchased Avidity Biosciences, Inc. (RNA) in Q4 2021, acquiring 11,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Avidity Biosciences, Inc. (RNA) for 15 quarters since Q4 2021.
Renaissance Technologies's largest addition to Avidity Biosciences, Inc. (RNA) was in Q2 2024, adding 377,400 shares worth $15.42 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 45,100 shares of Avidity Biosciences, Inc. (RNA), valued at approximately $3.25 M.
As of the Q4 2025 filing, Avidity Biosciences, Inc. (RNA) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Avidity Biosciences, Inc. (RNA) was 377,400 shares, as reported at the end of Q2 2024.